Refine by
Oncology Service Provider
33 companies found
Service providerbased inLinköping, SWEDEN
Driven by knowledge and passion, our vision is to contribute to a healthier and safer society. Sectra successfully develops and sells cutting-edge solutions in the expanding niche segments of medical IT and cybersecurity. The Sectra Group has some ...
Sectra’s enterprise imaging portfolio gives you a unified strategy for all your imaging needs, and lets you improve patient outcome while lowering operational costs. With our solutions, you can reduce the number of systems while providing ...
Service providerbased inWarminster (Ivyland), PENNSYLVANIA (USA)
Lyophilization Technology, Inc. (LTI) is a Contract Development & Manufacturing Organization (CDMO) focused on all aspects of lyophilization for preparation of health care products. To the benefit of our clients, LTI has provided Development and ...
Service providerbased inCraigavon, UNITED KINGDOM
The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. Our innovative ...
We are uniquely placed to partner with clients throughout the entire process of CDx Development through our Clinical Trial Diagnostic ...
Service providerbased inBrignais, FRANCE
Appolon Bioteck is a French research-focused healthcare company with combined strengths in Medical genetic diagnostics, oncology, virology and inflammation. We provide diagnostic tools that enable tangible improvements in the health, quality of life ...
Companion diagnostics is becoming a key element in cancer treatment. New predictive biomarkers and molecular strategies for personalized cancer therapies are currently available to treat each individual patient depending on the genetic ...
Service providerbased in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
Small molecules predominantly modulate the activity of their protein targets. The majority of approved small molecule inhibitors target intracellular kinases, which regulate cell signaling by transferring phosphate groups to target proteins. ...
Service providerbased inHatfield, PENNSYLVANIA (USA)
Allergenis is developing precision diagnostic solutions to help healthcare providers and patients better understand and manage their food allergies. Specializing in immunology and bioinformatics, we created a highly multiplexed analytical platform ...
At allergenis we have perfected the science behind the peanut allergy test and it’s different, a good kinda different. Never before has a blood test been able to help you make the decisions you have to make every single day living with food ...
Service providerbased inCambridge, MASSACHUSETTS (USA)
Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with ...
We plan to initiate patient screening for a first-in-human Phase 1 study of NTLA-5001, a WT1-directed TCR T cell therapy for the treatment of AML, by the end of 2021. Our first ex vivo development candidate seeks to treat acute myeloid leukemia ...
Service providerbased inEAGAN, MINNESOTA (USA)
Predictive Oncology Inc. (NASDAQ: POAI) is a data and AI-driven discovery services company that provides predictive models of tumor drug response that are used to improve clinical outcomes for patients. A multi-faceted, knowledge-driven company ...
Service providerbased inParis, FRANCE
Ipsen is a global biopharmaceutical group dedicated to improving lives and health outcomes through innovative medicines in Oncology, Neuroscience and Rare Disease. We also have a well-established and successful Consumer Healthcare business. We are ...
Service providerbased inHamburg, GERMANY
Indivumed GmbH was founded in 2002 by leading scientists with a drive to revolutionize cancer treatment through individualized therapy. As a physician-led, integrated global oncology company our experts leverage the world’s premier multi-omics ...
The outcome of your research is directly linked to the quality of the used biospecimen. In order to reflect the molecular reality, the biospecimen quality benefits from our standardized sampling by Indivumed study nurses and Indivumed trained ...
Service providerbased inWarren, NEW JERSEY (USA)
Auspex Diagnostics focuses on developing and providing advanced cancer diagnostics services to medical professionals and patients to help them personalize cancer treatment plans and improve patients’ quality of living. We started developing the ...
Auspex Diagnostic’s colorectal cancer test is a revolutionary treatment planning tool that can help stage II and III colorectal cancer patients and doctors personalize the treatment to the individual patient’s genes. Since no two ...
Service providerbased inNew York, NEW YORK (USA)
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. At Delcath, we look beyond the ordinary and strive for excellence in all that we do. Our investigational product, HEPZATO™ ...
Delcath has developed a percutaneous targeted, whole-organ treatment that delivers a select high-dose chemotherapy agent directly to the liver, while controlling systemic side effects, by filtering the chemotherapeutic agent from the blood before ...
Service providerbased inMorrisville, NORTH CAROLINA (USA)
Istari Oncology, Inc., is a clinical-stage biotechnology company developing innovative immunotherapies for the treatment of patients with solid tumors. Istari has built a passionate and experienced leadership team focused on clinical trial strategy ...
The tumor environment contains all the ingredients needed to mount an anticancer immune response—tumor antigens, antigen presenting cells (APCs, including tumor-associated macrophages [TAMs] and dendritic cells), and T cells—but ...
Service providerbased inGlasgow, UNITED KINGDOM
Our mission is to enhance decision making within R&D by leveraging Digital Pathology to deliver robust data and actionable insights. OracleBio is a global leader in quantitative digital pathology, providing image analysis services to Pharma and ...
At OracleBio, we have extensive experience in providing pre-clinical services to support clients in the early stages of the drug discovery pipeline. We understand that our clients need their data quickly, so we work hard to ensure a fast ...
Service providerbased inNew Haven, CONNECTICUT (USA)
Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. Our goal is to assist oncologists in providing the best care for their patients. At the intersection of academia, cancer ...
Service providerbased inSunnyvale, CALIFORNIA (USA)
Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond. Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company that develops, ...
Image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT) featuring integrated 3D image guidance, and highly conformal treatments enabled by a unique binary MLC. ...
Service providerbased inSan Jose, CALIFORNIA (USA)
Resolve Biosciences is applying the power of Molecular Cartography™ to enable scientists to gain new insights based on the highest-resolution view of single-cell spatial biology. The platform features the company's proprietary, multiplexed, ...
Our Molecular Cartography platform is a groundbreaking multi-analyte, highly multiplex spatial analysis technology that enables scientists to resolve the most complex biological challenges in areas such as oncology, neuroscience, ...
Service providerbased inFort Myers, FLORIDA (USA)
NeoGenomics is a premier cancer diagnostic, pharma services, and information services company serving oncologists, pathologists, pharmaceutical companies, and academic centers in their pursuit of providing better futures for people living with ...
Cytogenetics is the study of normal and abnormal chromosomes in relation to disease. Sometimes called chromosome analysis or karyotyping, cytogenetic tests are used to gain diagnostic and prognostic insights regarding solid tumor cancers and ...
Service providerbased inPalo Alto, CALIFORNIA (USA)
Lucence is a precision oncology company committed to bringing clarity to cancer care. Lucence makes ultrasensitive non-invasive liquid biopsy tests to provide doctors and their patients life-changing information to enable earlier detection and ...
Service providerbased inWroclaw, POLAND
Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based ...